Abstract
ObjectiveTo evaluate the efficacy and safety of tabalumab, a monoclonal antibody that neutralises membrane-bound and soluble B-cell activating factor (BAFF), in patients with active rheumatoid arthritis (RA) who showed inadequate...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have